Bioline Rx reported $28.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Arca Biopharma USD 355.16M 23.15M Sep/2025
Bio Path USD 680K 1.44M Jun/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 100.95M 23.18M Sep/2025